Prof. &#220;NAL EGELİ

Eryilmaz I. E., Egeli Ü., Cecener G.

CANCER BIOLOGY & THERAPY , vol.25, no.1, 2024 (SCI-Expanded) Sustainable Development

The Mutational and Transcriptional Landscapes of Speckle-Type POZ Protein (SPOP) and Androgen Receptor (AR) in a Single-Center pT3 Prostatectomy Cohort.

Eryilmaz I. E., Vuruskan B. A., Kaygisiz O., Cecener G., Egeli U., Vuruskan H.

Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer , vol.43, no.1, pp.15-29, 2024 (SCI-Expanded) Sustainable Development

Investigation of miR-146a expression profiles in fecal samples of patients with multiple sclerosis for early diagnosis and treatment

Unlu H., Sarıdaş F., Taskapilioglu O., Çeçener G., Egeli Ü., Turan Ö. F., et al.

Neurological Sciences and Neurophysiology , vol.40, no.2, pp.81-87, 2023 (SCI-Expanded) Sustainable Development

The regulatory effect of cabazitaxel on epithelial-mesenchymal transition in metastatic prostate cancer.

Eryılmaz I. E., Eskiler G. G., Egeli Ü., Çeçener G.

Journal of cancer research and therapeutics , vol.19, no.Supplement, 2023 (SCI-Expanded) Sustainable Development

An in vitro redox adaptation model for metastatic prostate cancer: Establishing, characterizing and Cabazitaxel response evaluating.

Clinical and experimental pharmacology & physiology , vol.49, no.10, pp.1094-1104, 2022 (SCI-Expanded) Sustainable Development

Identification of CHEK2 germline mutations in BRCA1/2 and PALB2 negative breast and ovarian cancer patients.

Aksoy F., Tezcan Unlu H., Cecener G., Guney Eskiler G., Egeli Ü., Tunca B., et al.

Human heredity , vol.87, pp.21-33, 2022 (SCI-Expanded)

Correlation between Ubiquitin E3 Ligases (SIAHs) and Heat Shock Protein 90 in Breast Cancer Patients

Takanlou L. S., ÇEÇENER G., Takanlou M. S., Nazlioglu H. O., Unlu H. T., IŞIK Ö., et al.

IRANIAN JOURNAL OF PUBLIC HEALTH , vol.51, no.8, pp.1836-1846, 2022 (SCI-Expanded) Sustainable Development

Investigation of VHL gene associated with miR-223 in clear cell renal cell carcinoma

Unal U., Çeçener G., Unlu H. T., Aytaç Vuruşkan B., Erdem E. E., Egeli Ü., et al.

MOLECULAR BIOLOGY REPORTS , vol.49, no.3, pp.2073-2083, 2022 (SCI-Expanded) Sustainable Development

The Anticancer Effect of Inula viscosa Methanol Extract by miRNAs' Re-regulation: An in vitro Study on Human Malignant Melanoma Cells.

Colak D. K., Egeli Ü., Eryilmaz I. E., Aybastier O., Malyer H., Cecener G., et al.

Nutrition and cancer , vol.74, no.1, pp.211-224, 2022 (SCI-Expanded)

Olea europaea leaf extract suppress stemness-Characteristics of gastric cancer via long non-coding RNAs

Tekin C., Ercelik M., TEZCAN G., AKSOY M. S., EGELİ Ü., ÇEÇENER G., et al.

EUROPEAN JOURNAL OF INTEGRATIVE MEDICINE , vol.49, 2022 (SCI-Expanded) Sustainable Development

The expression and prognostic value of miR-146a and miR-155 in Turkish patients with multiple sclerosis

Saridas F., Unlu H. T., Çeçener G., Egeli Ü., Takanlou M. S., Takanlou L. S., et al.

NEUROLOGICAL RESEARCH , vol.44, no.3, pp.217-223, 2022 (SCI-Expanded) Sustainable Development

Olea europaea leaf extract decreases tumour size by affecting the LncRNA expression status in glioblastoma 3D cell cultures

Mutlu M., TUNCA B., Aksoy S., Tekin C., ÇEÇENER G., EGELİ Ü.

European Journal of Integrative Medicine , vol.45, 2021 (SCI-Expanded) Sustainable Development

Evaluation of the Clinical Features Accompanied by the Gene Mutations: The 2 Novel PSEN1 Variants in a Turkish Early-onset Alzheimer Disease Cohort.

Eryilmaz I. E., Bakar M., Egeli Ü., Cecener G., Yurdacan B., Colak D. K., et al.

Alzheimer disease and associated disorders , vol.35, no.3, pp.214-222, 2021 (SCI-Expanded)

Association between the anticancer efficacy of cabazitaxel and toll-like receptor 4 mediating signaling pathways in metastatic castration-resistant prostate cancer cells.

Guney Eskiler G., Ozkan A. D., Eryilmaz I. E., Egeli Ü., Cecener G.

Human & experimental toxicology , vol.40, no.7, pp.1122-1129, 2021 (SCI-Expanded) Sustainable Development

NEAT1 Is a Novel Oncogenic LncRNA and Correlated with miR-143 in Pediatric Oligodendrogliomas

Ak Aksoy S., Mutlu M., Balcin R. N., Taskapilioglu M. Ö., Tekin C., Kaya S., et al.

PEDIATRIC NEUROSURGERY , vol.56, no.2, pp.133-139, 2021 (SCI-Expanded) Sustainable Development

DPYD c.1905 + 1G>A Promotes Fluoropyrimidine-Induced Anemia, a Prognostic Factor in Disease-Free Survival, in Colorectal Cancer.

Deligonul A., Aksoy S., Tezcan G., Tunca B., Kanat O., Cubukcu E., et al.

Genetic testing and molecular biomarkers , vol.25, no.4, pp.276-283, 2021 (SCI-Expanded) Sustainable Development

Comparison of Clinical and Molecular Wnt and SHH Subgroups in Medulloblastoma Tumor Cases.

Kaya I. S., Aksoy S., Mutlu M., Tekin C., Taskapilioglu M. Ö., Tunca B., et al.

Turkish neurosurgery , vol.31, no.4, pp.554-565, 2021 (SCI-Expanded)

Inhibitory Effects of Olea europaea Leaf Extract on Mesenchymal Transition Mechanism in Glioblastoma Cells.

Mutlu M., TUNCA B., Ak Aksoy S., Tekin C., EGELİ Ü., ÇEÇENER G.

Nutrition and cancer , vol.73, pp.713-720, 2021 (SCI-Expanded)

Contribution of functional dopamine D2 and D3 receptor variants to motor and non-motor symptoms of early onset Parkinson's disease

Eryılmaz I. E., Erer S., Zarifoğlu M., Egeli Ü., Karakus E., Yurdacan B., et al.

Clinical Neurology and Neurosurgery , vol.199, 2020 (SCI-Expanded)

Talazoparib nanoparticles for overcoming multidrug resistance in triple-negative breast cancer

JOURNAL OF CELLULAR PHYSIOLOGY , vol.235, no.9, pp.6230-6245, 2020 (SCI-Expanded) Sustainable Development

Long noncoding RNA MALAT1 may be a prognostic biomarker in IDH1/2 wild-type primary glioblastomas

ARGADAL Ö. G., Mutlu M., AKSOY S., KOCAELİ H., TUNCA B., Civan M. N., et al.

BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES , vol.20, no.1, pp.63-69, 2020 (SCI-Expanded) Sustainable Development

Clinicopathologic features and genetic characteristics of the BRCA1/2 mutation in Turkish breast cancer patients

ÇEÇENER G., Takanlou L. S., Takanlou M. S., EGELİ Ü., Eskiler G. G., AKSOY S., et al.

CANCER GENETICS , vol.240, pp.23-32, 2020 (SCI-Expanded) Sustainable Development

THE EXPRESSION STATUS OF CANCER STEM CELL MARKERS MAY PREDICT POOR PROGNOSIS IN PATIENTS UNDERGOING LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA

AKSOY F., DÜNDAR H. Z., AKSOY S., TUNCA B., TAŞAR P., UĞRAŞ N., et al.

TRANSPLANT INTERNATIONAL , vol.32, pp.346, 2019 (SCI-Expanded) Sustainable Development

RECURRENT HEPATOCELLULAR CARCINOMA AFTER LIVER TRANSPLANTATION: IDENTIFYING THE HIGH-RISK PATIENT USING THE EXPRESSION PROFILES OF EMT-ASSOCIATED LNCRNAS

AKSOY S., AKSOY F., DÜNDAR H. Z., TUNCA B., TAŞAR P., UĞRAŞ N., et al.

TRANSPLANT INTERNATIONAL , vol.32, pp.345, 2019 (SCI-Expanded)

Oleuropein modulates glioblastoma miRNA pattern different from Olea europaea leaf extract.

Tezcan G., Aksoy S., Tunca B., Bekar A., Mutlu M., Cecener G., et al.

Human & experimental toxicology , vol.38, no.9, pp.1102-1110, 2019 (SCI-Expanded)

Synergistic effects of hormone therapy drugs and usnic acid on hormone receptor-positive breast and prostate cancer cells

Eskiler G. G., ERYILMAZ I. E., Yurdacan B., EGELİ Ü., ÇEÇENER G., TUNCA B.

JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY , vol.33, no.8, 2019 (SCI-Expanded) Sustainable Development

Investigation of new treatment option for hepatocellular carcinoma: a combination of sorafenib with usnic acid

Yurdacan B., Egeli Ü., Eskiler G. G., Eryılmaz I. E., Çeçener G., Tunca B.

JOURNAL OF PHARMACY AND PHARMACOLOGY , vol.71, no.7, pp.1119-1132, 2019 (SCI-Expanded)

Overexpression of miR-21 Is Associated With Recurrence in Patients With Hepatitis B Virus-Mediated Hepatocellular Carcinoma Undergoing Liver Transplantation

Dundar H. Z., Aksoy F., Aksoy S., Tasar P., Ugras N., Tunca B., et al.

TRANSPLANTATION PROCEEDINGS , vol.51, no.4, pp.1157-1161, 2019 (SCI-Expanded) Sustainable Development

BMN 673 (talazoparib): A potent PARP inhibitor for triple negative breast cancer with different genetic profile

JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY , vol.33, no.5, 2019 (SCI-Expanded) Sustainable Development

RNA-based markers in biopsy cores with atypical small acinar proliferation: Predictive effect of T2E fusion positivity and MMP-2 upregulation for a subsequent prostate cancer diagnosis

Eryılmaz I. E., Aytaç Vuruşkan B., Kaygısız O., Egeli Ü., Tunca B., Kordan Y., et al.

PROSTATE , vol.79, no.2, pp.195-205, 2019 (SCI-Expanded) Sustainable Development

The role of usnic acid-induced apoptosis and autophagy in hepatocellular carcinoma.

Yurdacan B., Egeli Ü., Eskiler G. G., Eryilmaz I. E., Cecener G., Tunca B.

Human & experimental toxicology , vol.38, no.2, pp.201-215, 2019 (SCI-Expanded) Sustainable Development

Talazoparib Loaded Solid Lipid Nanoparticles: Preparation, Characterization and Evaluation of the Therapeutic Efficacy In Vitro

Eskiler G. G., ÇEÇENER G., DİKMEN G., EGELİ Ü., TUNCA B.

CURRENT DRUG DELIVERY , vol.16, no.6, pp.511-529, 2019 (SCI-Expanded) Sustainable Development

Prediction of breast cancer metastasis risk using circulating tumor markers: A follow-up study

ÇETİNTAŞ S., Tezcan G., TUNCA B., EGELİ Ü., GÖKGÖZ M. Ş., ÇEÇENER G.

BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES , vol.19, no.2, pp.172-179, 2019 (SCI-Expanded) Sustainable Development

Synthetically Lethal BMN 673 (Talazoparib) Loaded Solid Lipid Nanoparticles for BRCA1 Mutant Triple Negative Breast Cancer

PHARMACEUTICAL RESEARCH , vol.35, no.11, 2018 (SCI-Expanded) Sustainable Development

In vitro cytotoxic and antiproliferative effects of usnic acid on hormone-dependent breast and prostate cancer cells

ERYILMAZ I. E., Eskiler G. G., EGELİ Ü., Yurdacan B., ÇEÇENER G., TUNCA B.

JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY , vol.32, no.10, 2018 (SCI-Expanded) Sustainable Development

Solid lipid nanoparticles: Reversal of tamoxifen resistance in breast cancer

Eskiler G. G., ÇEÇENER G., DİKMEN G., EGELİ Ü., TUNCA B.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES , vol.120, pp.73-88, 2018 (SCI-Expanded) Sustainable Development

Triple negative breast cancer: new therapeutic approaches and BRCA status

Eryılmaz I. E., Çolakoğlu Bergel C., Arıöz B., Egeli Ü.

APMIS , vol.126, no.5, pp.371-379, 2018 (SCI-Expanded) Sustainable Development

Expressed Gene Fusions as Frequent Drivers of Poor Outcomes in Hormone Receptor-Positive Breast Cancer

Matissek K. J., Onozato M. L., Sun S., Zheng Z., Schultz A., Lee J., et al.

CANCER DISCOVERY , vol.8, no.3, pp.336-353, 2018 (SCI-Expanded) Sustainable Development

Coexistence of MACC1 and NM23-H1 dysregulation and tumor budding promise early prognostic evidence for recurrence risk of early-stage colon cancer.

Ozturk E., Aksoy S., Uğraş N., Tunca B., Ceylan S., Tezcan G., et al.

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica , vol.126, no.2, pp.99-108, 2018 (SCI-Expanded) Sustainable Development

Overexpression of the Long Noncoding RNA HomeoboxA Transcript at the Distal Tip Predicts Poor Prognosis in a KRAS-Independent Manner in Periampullary Region Tumors

Balcin O., AKSOY S., TUNCA B., KAYA E., EGELİ Ü., Tezcan G., et al.

PANCREAS , vol.47, no.2, pp.213-220, 2018 (SCI-Expanded) Sustainable Development

Olea europaea leaf extract and bevacizumab synergistically exhibit beneficial efficacy upon human glioblastoma cancer stem cells through reducing angiogenesis and invasion in vitro

Tezcan G., Taşkapılıoğlu M. Ö., Tunca B., Bekar A., Demirci H., Kocaeli H., et al.

BIOMEDICINE & PHARMACOTHERAPY , vol.90, pp.713-723, 2017 (SCI-Expanded) Sustainable Development

Epigenetic approach to early-onset Parkinson's disease: low methylation status of SNCA and PARK2 promoter regions

Eryılmaz I. E., Çeçener G., Erer S., Egeli Ü., Tunca B., Zarifoğlu M., et al.

NEUROLOGICAL RESEARCH , vol.39, no.11, pp.965-972, 2017 (SCI-Expanded)

Olea europaea Leaf Extract Improves the Efficacy of Temozolomide Therapy by Inducing MGMT Methylation and Reducing P53 Expression in Glioblastoma

Tezcan G., TUNCA B., Demirci H., BEKAR A., TAŞKAPILIOĞLU M. Ö., KOCAELİ H., et al.

NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL , vol.69, no.6, pp.873-880, 2017 (SCI-Expanded)

An in vitro model for the development of acquired tamoxifen resistance

Eskiler G. G., ÇEÇENER G., TUNCA B., EGELİ Ü.

CELL BIOLOGY AND TOXICOLOGY , vol.32, no.6, pp.563-581, 2016 (SCI-Expanded) Sustainable Development

Association of PALB2 sequence variants with the risk of early-onset breast cancer in patients from Turkey.

Cecener G., Eskiler G. G., Egeli Ü., Tunca B., Alemdar A., Gokgoz S., et al.

Molecular biology reports , vol.43, no.11, pp.1273-1284, 2016 (SCI-Expanded) Sustainable Development

miR-216b Targets FGFR1 and Confers Sensitivity to Radiotherapy in Pancreatic Ductal Adenocarcinoma Patients Without EGFR or KRAS Mutation.

EGELİ Ü., Tezcan G., ÇEÇENER G., TUNCA B., Sevinc E. D., KAYA E., et al.

Pancreas , vol.45, no.9, pp.1294-302, 2016 (SCI-Expanded)

Expression and clinical significance of miRNAs that may be associated with the FHIT gene in breast cancer.

Sevinc E. D., ÇEÇENER G., Ak S., TUNCA B., EGELİ Ü., Gokgoz S., et al.

Gene , vol.590, no.2, pp.278-84, 2016 (SCI-Expanded) Sustainable Development

Mutation analysis of the PARKIN, PINK1, DJ1, and SNCA genes in Turkish early-onset Parkinson's patients and genotype-phenotype correlations.

Erer S., Egeli Ü., Zarifoğlu M., Tezcan G., Çeçener G., Tunca B., et al.

Clinical neurology and neurosurgery , vol.148, pp.147-53, 2016 (SCI-Expanded)

A novel [Mn2(μ-(C6H5)2CHCOO)2(bipy)4](bipy)(ClO4)2 complex loaded solid lipid nanoparticles: synthesis, characterization and in vitro cytotoxicity on MCF-7 breast cancer cells.

Eskiler G. G., Cecener G., Dikmen G., Kani I., Egeli Ü., Tunca B.

Journal of microencapsulation , vol.33, no.6, pp.575-584, 2016 (SCI-Expanded) Sustainable Development

Association of MDR1, CYP2D6, and CYP2C19 gene polymorphisms with prophylactic migraine treatment response.

Atasayar G., Eryılmaz I. E., Karli N., Egeli Ü., Zarifoğlu M., Çeçener G., et al.

Journal of the neurological sciences , vol.366, pp.149-154, 2016 (SCI-Expanded)

Impact of 3'UTR variation patterns of the KRAS gene on the aggressiveness of pancreatobiliary tumors with the KRAS G13D mutation in a Turkish population.

EGELİ Ü., Ak S., ÇEÇENER G., TUNCA B., Tezcan G., Sevinc E. D., et al.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] , vol.16, no.4, pp.677-86, 2016 (SCI-Expanded)

Molecular approach to genetic and epigenetic pathogenesis of early-onset colorectal cancer

Tezcan G., TUNCA B., Ak S., ÇEÇENER G., EGELİ Ü.

WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY , vol.8, no.1, pp.83-98, 2016 (SCI-Expanded) Sustainable Development

Circulating miR 195 as a Therapeutic Biomarker in Turkish Breast Cancer Patients

Çeçener G., Ak S., Güney G., Sevinç Demirdöğen E., Ertürk E., Gökgöz M. Ş., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.17, pp.4241-4246, 2016 (SCI-Expanded) Sustainable Development

The Anticancer Activity of Complex [Cu-2(mu-(C6H5)(2)CHCOO)(3)(bipy)(2))](ClO4) -Solid Lipid Nanoparticles on MCF-7 Cells

KANİ İ., DİKMEN G., Eskiler G. G., ÇEÇENER G., TUNCA B., EGELİ Ü.

CURRENT DRUG DELIVERY , vol.13, no.8, pp.1339-1350, 2016 (SCI-Expanded) Sustainable Development

Circulating miR-195 as a Therapeutic Biomarker in Turkish Breast Cancer Patients.

Çeçener G., Ak S., Eskiler G. G., Demirdogen E., Ertürk E., Gokgoz S., et al.

Asian Pacific journal of cancer prevention : APJCP , vol.17, no.9, pp.4241-4246, 2016 (SCI-Expanded) Sustainable Development

Ficus carica Latex Prevents Invasion Through Induction of Let-7d Expression in GBM Cell Lines

Tezcan G., TUNCA B., BEKAR A., YALÇIN M., ŞAHİN S., BUDAK F., et al.

CELLULAR AND MOLECULAR NEUROBIOLOGY , vol.35, no.2, pp.175-187, 2015 (SCI-Expanded) Sustainable Development

BRCA mutations cause reduction in miR-200c expression in triple negative breast cancer

Ertürk E., Çeçener G., Tezcan G., Egeli Ü., Tunca B., Gokgoz S., et al.

GENE , vol.556, no.2, pp.163-169, 2015 (SCI-Expanded) Sustainable Development

Association of miR-1266 with recurrence/metastasis potential in estrogen receptor positive breast cancer patients

Sevinc E. D., EGELİ Ü., ÇEÇENER G., Tezcan G., TUNCA B., Gokgoz S., et al.

Asian Pacific Journal of Cancer Prevention , vol.16, no.1, pp.291-297, 2015 (SCI-Expanded) Sustainable Development

Expression status of let-7a and miR-335 among breast tumors in patients with and without germ-line BRCA mutations

Ertürk E., Çeçener G., Egeli Ü., Tunca B., Tezcan G., Gokgoz S., et al.

MOLECULAR AND CELLULAR BIOCHEMISTRY , vol.395, pp.77-88, 2014 (SCI-Expanded) Sustainable Development

BRCA1/2 germline mutations and their clinical importance in Turkish breast cancer patients.

Çeçener G., Egeli Ü., Tunca B., Ertürk E., Ak S., Gokgoz S., et al.

Cancer investigation , vol.32, no.8, pp.375-87, 2014 (SCI-Expanded) Sustainable Development

MicroRNA expression patterns of tumors in early-onset colorectal cancer patients.

Ak S., TUNCA B., Tezcan G., ÇEÇENER G., EGELİ Ü., Yilmazlar T., et al.

The Journal of surgical research , vol.191, no.1, pp.113-22, 2014 (SCI-Expanded) Sustainable Development

microRNA Expression Pattern Modulates Temozolomide Response in GBM Tumors with Cancer Stem Cells

Tezcan G., TUNCA B., BEKAR A., Preusser M., Berghoff A. S., EGELİ Ü., et al.

CELLULAR AND MOLECULAR NEUROBIOLOGY , vol.34, no.5, pp.679-692, 2014 (SCI-Expanded) Sustainable Development

The expression level of MACC1 in early stage CRC patients of Turkish population

Ceylan S., Ak S., Tunca B., Ozturk E., Tezcan G., Cecener G., et al.

EUROPEAN JOURNAL OF CANCER , vol.50, 2014 (SCI-Expanded)

Ficus carica latex inhibits GBM cell proliferation by modulating let-7d expression

Tezcan G., Tunca B., Bekar A., Cecener G., Egeli Ü., Malyer H.

EUROPEAN JOURNAL OF CANCER , vol.50, 2014 (SCI-Expanded)

Evaluation of microRNA expression profiles in triple-negative (ER, PR and Her2/neu) breast cancer patients with and without germ-line BRCA mutations

Erturk E., Cecener G., Egeli Ü., Tunca B., Tezcan G., Gokgoz S., et al.

EUROPEAN JOURNAL OF CANCER , 2014 (SCI-Expanded) Sustainable Development

Evaluation of genetic variations in miRNA-binding sites of BRCA1 and BRCA2 genes as risk factors for the development of early-onset and/or familial breast cancer.

Ertürk E., Çeçener G., Polatkan V., Gokgoz S., Egeli Ü., Tunca B., et al.

Asian Pacific journal of cancer prevention : APJCP , vol.15, no.19, pp.8319-24, 2014 (SCI-Expanded) Sustainable Development

Molecular Markers for Patients with Thymic Malignancies: not Feasible at Present?

Avci N., Çeçener G., Deligönül A., Ertürk E., Tunca B., Egeli Ü., et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.15, no.8, pp.3457-3460, 2014 (SCI-Expanded)

Olea europaea leaf extract improves the treatment response of GBM stem cells by modulating miRNA expression

Tezcan G., TUNCA B., BEKAR A., BUDAK F., ŞAHİN S., ÇEÇENER G., et al.

AMERICAN JOURNAL OF CANCER RESEARCH , vol.4, no.5, pp.572-590, 2014 (SCI-Expanded) Sustainable Development

Microsatellite instability status affects gene expression profiles in early onset colorectal cancer patients.

Ak S., Tunca B., Yilmazlar T., Tezcan G., Çeçener G., Egeli Ü., et al.

The Journal of surgical research , vol.185, no.2, pp.626-37, 2013 (SCI-Expanded) Sustainable Development

Overexpression of CK20, MAP3K8 and EIF5A correlates with poor prognosis in early-onset colorectal cancer patients

TUNCA B., Tezcan G., ÇEÇENER G., EGELİ Ü., Zorluoglu A., Yilmazlar T., et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY , vol.139, no.4, pp.691-702, 2013 (SCI-Expanded) Sustainable Development

Olea europaea leaf extract alters microRNA expression in human glioblastoma cells

TUNCA B., Tezcan G., ÇEÇENER G., EGELİ Ü., Ak S., MALYER H., et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY , vol.138, no.11, pp.1831-1844, 2012 (SCI-Expanded) Sustainable Development

The Promoter Hypermethylation Status of GATA6, MGMT, and FHIT in Glioblastoma

Çeçener G., Tunca B., Egeli Ü., Bekar A., Tezcan G., Ertürk E., et al.

CELLULAR AND MOLECULAR NEUROBIOLOGY , vol.32, no.2, pp.237-244, 2012 (SCI-Expanded) Sustainable Development

CK19, CK20, EGFR and HER2 status of circulating tumor cells in patients with breast cancer

Tunca B., Egeli Ü., Çeçener G., Tezcan G., Gokgoz S., Tasdelen L., et al.

TUMORI JOURNAL , vol.98, no.2, pp.243-251, 2012 (SCI-Expanded) Sustainable Development

Analysis of mismatch repair gene mutations in Turkish HNPCC patients

TUNCA B., Pedroni M., ÇEÇENER G., EGELİ Ü., Borsi E., Zorluoglu A., et al.

FAMILIAL CANCER , vol.9, no.3, pp.365-376, 2010 (SCI-Expanded) Sustainable Development

FHIT Gene Sequence Variants and Reduced Fhit Protein Expression in Glioblastoma Multiforme

ÇEÇENER G., TUNCA B., EGELİ Ü., BEKAR A., Guler G., TOLUNAY Ş., et al.

CELLULAR AND MOLECULAR NEUROBIOLOGY , vol.30, no.2, pp.301-307, 2010 (SCI-Expanded) Sustainable Development

Investigation of MMAC/PTEN Gene Mutations and Protein Expression in Low Grade Gliomas

ÇEÇENER G., TUNCA B., EGELİ Ü., BEKAR A., Guler G., VATAN Ö., et al.

CELLULAR AND MOLECULAR NEUROBIOLOGY , vol.29, no.5, pp.733-738, 2009 (SCI-Expanded)

Mutation analysis of the FHIT gene in bronchoscopic specimens from patients with suspected lung cancer

ÇEÇENER G., TUNCA B., EGELİ Ü., KARADAĞ M., VATAN Ö., Uzaslan E., et al.

TUMORI , vol.94, no.6, pp.845-848, 2008 (SCI-Expanded) Sustainable Development

The mutation spectrum of the APC gene in Turkish patients with familial adenomatous polyposis.

Tunca B., Cecener G., Egeli Ü., Zorluoglu A., Yilmazlar T.

Diseases of the colon and rectum , vol.50, no.11, pp.1899-904, 2007 (SCI-Expanded)

Importance of novel sequence alterations in the FHIT gene on formation of breast cancer

ÇEÇENER G., Egeli Ü., TUNCA B., Tasdelen I., TOLUNAY Ş., Bilgel N.

TUMORI J , vol.93, no.6, pp.597-603, 2007 (SCI-Expanded) Sustainable Development

Low frequency of p53 and k-ras codon 12 mutations in non-small cell lung carcinoma (NSCLC) tumors and surgical margins

VATAN Ö., Bilaloglu R., TUNCA B., ÇEÇENER G., GEBİTEKİN C., EGELİ Ü., et al.

TUMORI J , vol.93, no.5, pp.473-477, 2007 (SCI-Expanded) Sustainable Development

Impact of novel PTEN mutations in Turkish patients with glioblastoma multiforme.

Tunca B., Bekar A., Cecener G., Egeli Ü., Vatan Ö., Tolunay S., et al.

Journal of neuro-oncology , vol.82, no.3, pp.263-9, 2007 (SCI-Expanded)

Correlation of chromosomal imbalances by comparative genomic hybridization and expression of EGFR, PTEN, p53, and MIB-1 in diffuse gliomas

Yakut T., Gutenberg A., Bekar A., Egeli Ü., Gunawan B., Ercan İ., et al.

ONCOLOGY REPORTS , vol.17, no.5, pp.1037-1043, 2007 (SCI-Expanded)

LEFT PAIN DUE TO ECTOPIC THYMOMA

Solmaz D., Ozay P., EGELİ Ü., Ozaslan H., Afacan I.

JBR-BTR , vol.90, no.3, pp.208-209, 2007 (SCI-Expanded)

P53 gene mutations in surgical margins and primary tumor tissues of patients with squamous cell carcinoma of the head and neck.

Tunca B., Erisen L., Coskun H., Cecener G., Ozuysal S., Egeli Ü.

Tumori , vol.93, no.2, pp.182-8, 2007 (SCI-Expanded) Sustainable Development

Investigation of mutations and expression of the FHIT gene in Turkish patients with brain metastases derived from non-small cell lung cancer

BEKAR A., Cecener G., TUNCA B., Guler G., EGELİ Ü., TOLUNAY Ş.

Tumori , vol.93, no.6, pp.604-607, 2007 (SCI-Expanded) Sustainable Development

Assessment of molecular events in squamous and non-squamous cell lung carcinoma

Yakut T., Schulten H., Demir A., Frank D., Danner B., Egeli Ü., et al.

LUNG CANCER , vol.54, no.3, pp.293-301, 2006 (SCI-Expanded) Sustainable Development

Analysis of p53 gene mutations in parapsoriasis

Baskan E. B., Tunca B., Cecener G., Tunali S., Egeli Ü., Saricaoglu H., et al.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY , no.7, pp.882-883, 2006 (SCI-Expanded)

Novel germline BRCA1 and BRCA2 mutations in Turkish women with breast and/or ovarian cancer and their relatives.

Egeli Ü., Cecener G., Tunca B., Tasdelen I.

Cancer investigation , vol.24, no.5, pp.484-91, 2006 (SCI-Expanded) Sustainable Development

Meiotic segregation analysis of reciprocal translocations, both in sperms and blastomeres

Yakut T., Ercelen N., Acar H., Kimya Y., Egeli Ü.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A , no.10, pp.1074-1082, 2006 (SCI-Expanded)

Patchy spinal anesthesia

Suren M., Basaranoglu G., Bay B., Egeli Ü., Afacan I., Ozturk K., et al.

ANESTHESIA AND ANALGESIA , vol.102, no.4, pp.1290, 2006 (SCI-Expanded)

FISH investigation of 22q11.2 deletion in patients with immunodeficiency and/or cardiac abnormalities.

Yakut T., Kilic S. Ş., Cil E., Yapici E., Egeli Ü.

Pediatric surgery international , vol.22, no.4, pp.380-3, 2006 (SCI-Expanded)

Cytogenetic results of amniocentesis materials: Incidence of abnormal karyotypes in the Turkish collaborative study

Karaoguz M. Y., Bal F., Yakut T., Ercelen N. O., Ergun M. A., Gokcen A. B., et al.

GENETIC COUNSELING , vol.17, no.2, pp.219-230, 2006 (SCI-Expanded)

Investigation of APC mutations in a Turkish familial adenomatous polyposis family by heterodublex analysis.

Tunca B., Menigatti M., Benatti P., Egeli Ü., Cecener G., Pedroni M., et al.

Diseases of the colon and rectum , vol.48, no.3, pp.567-71, 2005 (SCI-Expanded) Sustainable Development

Investigation for aneuploidy of chromosomes 7, 9, 10, 17 and p53 gene deletions between low and high grade glial tumors using interphase fish technique

Yakut T., Bekar A., Egeli Ü., Doygun M., Ercan İ., Yigit B., et al.

NEUROSCIENCE RESEARCH COMMUNICATIONS , vol.35, no.2, pp.105-117, 2004 (SCI-Expanded)

Comparison of genetic changes between interphase and metapbase nuclei in monitoring CML and APL treatment using DC-FISH technique

Yakut T., Ali R., Egeli Ü., Ozkalemkas F., Ercan İ., Ozcelik T., et al.

CANCER BIOLOGY & THERAPY , vol.3, no.9, pp.858-863, 2004 (SCI-Expanded)

Frequency of recombinant and nonrecombinant products of pericentric inversion of chromosome 1 in sperm nuclei of carrier: By FISH technique

Yakut T., Acar H., Egeli Ü., Kimya Y.

MOLECULAR REPRODUCTION AND DEVELOPMENT , vol.66, no.1, pp.67-71, 2003 (SCI-Expanded)

Investigation of c-myc and p53 gene alterations in the tumor and surgical borderline tissues of NSCLC and effects on clinicopathologic behavior: By the FISH technique

Yakut T., Egeli Ü., Gebitekin C.

LUNG , vol.181, no.5, pp.245-258, 2003 (SCI-Expanded)

Esophageal atresia and tracheo-esophageal fistula in a patient with Digeorge syndrome.

Kilic S. Ş., Gurpinar A. N., Yakut T., Egeli Ü., Dogruyol H.

Journal of pediatric surgery , vol.38, no.8, 2003 (SCI-Expanded)

An unusual metastatic site of laryngeal carcinoma: scapular muscles

Yucel E., Demirel T., Demiryont M., Egeli Ü., Deger K.

JOURNAL OF LARYNGOLOGY AND OTOLOGY , vol.117, no.1, pp.85-87, 2003 (SCI-Expanded)

Prenatal diagnosis of a fetus with pure partial trisomy 1q32-44 due to a familial balanced rearrangement

Kimya Y., Yakut T., Egeli Ü., ÖZERKAN K. N.

PRENATAL DIAGNOSIS , vol.22, no.11, pp.957-961, 2002 (SCI-Expanded)

Investigation of genetic susceptibility to non-small cell lung cancer by fragile site expression

Tunca B., Cecener G., Gebitekin C., Egeli Ü., Ediz B., Ercan İ.

Teratogenesis Carcinogenesis and Mutagenesis , vol.22, no.3, pp.205-215, 2002 (SCI-Expanded) Sustainable Development

Investigation of genotoxic effect of taxol plus radiation on mice bone marrow cells.

Ozkan L., Egeli Ü., Tunca B., Aydemir N., Cecener G., AKPINAR G., et al.

Teratogenesis, carcinogenesis, and mutagenesis , vol.22, no.1, pp.1-11, 2002 (SCI-Expanded)

Determination of allelic deletion of multiple endocrine neoplasm type 1 (MEN1) gene in acute myeloid leukemia (AML) by application of FISH-TSA technique

Acar H., Kaynak M., Yakut T., Ucar F., Egeli Ü.

TERATOGENESIS CARCINOGENESIS AND MUTAGENESIS , vol.22, no.5, pp.369-375, 2002 (SCI-Expanded)

Evaluation of relationship between chromosome 22 and p53 gene alterations and the subtype of meningiomas by the interphase-FISH technique.

Yakut T., Bekar A., Doygun M., Acar H., Egeli Ü., Ogul E.

Teratogenesis, carcinogenesis, and mutagenesis , vol.22, no.3, pp.217-25, 2002 (SCI-Expanded)

Investigation of the genotoxic effect in bone marrow of Swiss albino mice exposed long-term to pyrimethamine.

Tunca B., Egeli Ü., Aydemir N., Cecener G., Bilaloglu R.

Teratogenesis, carcinogenesis, and mutagenesis , vol.22, no.6, pp.393-402, 2002 (SCI-Expanded) Sustainable Development

Chromosomal fragile sites and relationship between genetic predisposition to small cell lung cancer.

Karadag M., Tunca B., Cecener G., Engeli Ü., Ozyardimci N., Ege E., et al.

Teratogenesis, carcinogenesis, and mutagenesis , vol.22, no.1, pp.31-40, 2002 (SCI-Expanded) Sustainable Development

Effects of Taxol plus radiation on the apoptotic and mitotic indices of mouse intestinal crypt cells

Ozkan L., Ozuysal S., Egeli Ü., Adim Ş., Tunca B., Aydemir N., et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY , no.7, pp.433-438, 2001 (SCI-Expanded)

The relationship between genetic susceptibility to head and neck cancer with the expression of common fragile sites.

Egeli Ü., Ozkan L., Tunca B., Kahraman S., Cecener G., Ergul E., et al.

Head & neck , vol.22, no.6, pp.591-8, 2000 (SCI-Expanded) Sustainable Development

The expression frequency of common fragile sites and genetic predisposition to colon cancer.

Tunca B., Egeli Ü., Zorluoglu A., Yilmazlar T., Yerci O., Kizil A.

Cancer genetics and cytogenetics , vol.119, no.2, pp.139-45, 2000 (SCI-Expanded) Sustainable Development

The expression of fragile sites in lymphocytes of patients with rectum cancer and their first-degree relatives.

Tunca B., Egeli Ü., Zorluoglu A., Yilmazlar T., Yerci O., Kizil A.

Cancer letters , vol.152, no.2, pp.201-9, 2000 (SCI-Expanded) Sustainable Development

Genotoxic, hematoxic, pathological, and biochemical effects of hexane on Swiss albino rats.

Egeli Ü., Tunca B., Tuncel P., Kahraman M., Sevinir B., Cecener G., et al.

Teratogenesis, carcinogenesis, and mutagenesis , vol.20, no.6, pp.329-40, 2000 (SCI-Expanded)

Apoptotic effects of taxol and radiation an the intestinal kript cells of swiss-albino mice

Ozkan L., Ozuysal S., Egeli Ü., Balim S., Tunca B., Aydemir N., et al.

EUROPEAN JOURNAL OF CANCER , vol.35, 1999 (SCI-Expanded)

In vivo dominant lethal effect of pyrimethamine in male mouse germ cells.

Egeli Ü., Aydemir N., Akpmar G., Cimen C., Ergul E., Tutar G., et al.

Mutagenesis , vol.14, no.1, pp.67-9, 1999 (SCI-Expanded) Sustainable Development

Prenatal diagnosis of a fetus with balanced insertional translocation 13 (q21; q13)

Yakut T., Egeli Ü., Kimya Y., Tunca B., Saglan D.

CYTOGENETICS AND CELL GENETICS , vol.85, pp.61, 1999 (SCI-Expanded)

Common fragile site expression and genetic predisposition to breast cancer.

Cecener G., Egeli Ü., Tasdelen I., Tunca B., Duman H., Kizil A.

Teratogenesis, carcinogenesis, and mutagenesis , vol.18, no.6, pp.279-91, 1998 (SCI-Expanded) Sustainable Development

Induction of sister chromatid exchanges by pyrimethamine in human lymphocyte cultures

Egeli Ü.

TERATOGENESIS CARCINOGENESIS AND MUTAGENESIS , vol.18, no.4, pp.163-169, 1998 (SCI-Expanded) Sustainable Development

The expression of common fragile sites and genetic predisposition to squamous cell lung cancers.

Egeli Ü., Karadag M., Tunca B., Ozyardimci N.

Cancer genetics and cytogenetics , vol.95, no.2, pp.153-8, 1997 (SCI-Expanded) Sustainable Development

Detection of fragile sites induced by pyrimethamine.

Egeli Ü., Tunca B.

Teratogenesis, carcinogenesis, and mutagenesis , vol.17, no.2, pp.59-69, 1997 (SCI-Expanded) Sustainable Development

Cytogenetic findings on shoe workers exposed long-term to benzene

Tunca B., Egeli Ü.

ENVIRONMENTAL HEALTH PERSPECTIVES , vol.104, pp.1313-1317, 1996 (SCI-Expanded)

Analysis of chromosomal aberrations in shoe workers exposed long term to benzene.

TURKEL B., EGELI Ü.

Occupational and environmental medicine , vol.51, no.1, pp.50-3, 1994 (SCI-Expanded)

THE CLASTOGENIC EFFECT OF PYRIMETHAMINE (DARAPRIM) ON HUMAN-CHROMOSOMES IN LYMPHOCYTE-CULTURES

EGELI Ü., ERDOGAN G.

CELL BIOLOGY AND TOXICOLOGY , vol.7, no.4, pp.347-356, 1991 (SCI-Expanded) Sustainable Development

A molecular approach to genetic and epigenetic pathogenesis of early onset colorectal cancer

Tezcan G., TUNCA B., AK S., ÇEÇENER G., EGELİ Ü.

World Journal of Gastrointestinal Oncology , 1900 (SCI-Expanded) Sustainable Development

Articles Published in Other Journals 21

Biomarker Profiling for Discrimination of High-Risk Asymptomatic Carotid Artery Stenosis Patients with Ulcerated Plaques: A Pilot Study

Yolgösteren A., Çolakoğlu Bergel C., Egeli Ü., Eryılmaz I. E., Erdemli Gürsel B., Biçer M., et al.

Uludağ Üniversitesi Tıp Fakültesi Dergisi , vol.51, no.1, pp.93-99, 2025 (Peer-Reviewed Journal) Sustainable Development

Cytotoxic and Apoptotic Agent Encorafenib Controversially Alters Invasive Properties of Castration-Resistant Prostate Cancer Cells with High and Moderate Metastatic Potential

Osmangazi Tıp Dergisi , vol.47, no.2, pp.263-270, 2025 (Peer-Reviewed Journal) Sustainable Development

Genotyping Apolipoprotein E (APOE) Isoforms with Sequence-Specific-Primer (SSP)-PCR in Early‑Onset Alzheimer’s Disease Patients: A Rapid and Revised Methodology

Eryılmaz I. E., Bakar H. M., Egeli Ü., Çeçener G.

Uludağ Üniversitesi Tıp Fakültesi Dergisi , vol.50, no.2, pp.157-163, 2024 (Peer-Reviewed Journal) Sustainable Development

Ten-Year Recurrence Outcomes in Early Stage and Early Onset Colon Cancer and the Expression Profiles of MicroRNAs and Cancer Stem Cell Markers in These Tumors

Aksoy S. A., Tunca B., Yılmazlar T., Işık Ö., Öztürk E., Ercelik M., et al.

Online Türk Sağlık Bilimleri Dergisi , vol.8, no.1, pp.16-23, 2023 (Peer-Reviewed Journal)

The Activation of PI3K/AKT/mTOR Signaling Pathway in Response to Cabazitaxel Treatment in Metastatic Castration-Resistant Prostate Cancer Cells

ERYILMAZ I. E., GÜNEY ESKİLER G., Çolakoğlu C., EGELİ Ü., ÇEÇENER G.

European Journal of Biology , vol.80, no.2, pp.138-144, 2021 (Peer-Reviewed Journal) Sustainable Development

The Role of the Dopamine beta-hydroxylase Functional Polymorphism in Patients with Early-Onset Parkinson's Disease in the Turkish Population

Erer S., Eryılmaz I. E., Colak D. K., Egeli Ü., Çeçener G., Tunca B., et al.

TURKISH JOURNAL OF NEUROLOGY , vol.27, no.1, pp.21-26, 2021 (ESCI)

Reversal effect of quercetin on talazoparib resistance in BRCA1 mutant triple negative breast cancer

GÜNEY ESKİLER G., ÇEÇENER G., EGELİ Ü., TUNCA B.

The European Research Journal , vol.6, no.1, pp.19-25, 2020 (Peer-Reviewed Journal) Sustainable Development

Kodlama yapmayan RNA HOTTIP periampuller bölge tümörlerinde prognostik bir biyobelirteç adayıdır

AKSOY F., AK S., TUNCA B., EGELİ Ü., ÇEÇENER G., DÜNDAR H. Z., et al.

Turkish Journal of Surgery , 2017 (Scopus)

MikroRNA 10b’ nin yüksek ekspresyonu pankreatik duktal adenokarsinomlarda bağımsız bir prognostik parametre adayıdır

AK S., AKSOY F., TUNCA B., EGELİ Ü., ÇEÇENER G., DÜNDAR H. Z., et al.

Turkish Journal of Surgery , 2017 (Scopus)

Cytotoxicity of Juniperus excelsa Aqueous BerryExtract on Castration-Resistant Prostate CancerCells

Eryılmaz I. E., Egeli Ü., Malyer H., Çeçener G., Şahin S., Tunca B.

Turkish Journal of Molecular Biology Biotechnology , vol.2, no.01, pp.98, 2017 (Peer-Reviewed Journal) Sustainable Development

Prunella vulgaris L. ve Prunella grandiflora L.’den saflaştırılan Rosmarinik Asitin farklı tümör hücreleri üzerindeki sitotoksik aktivitesi.-Cytotoxic Activity of Rosmarinic Acid Isolated From Prunella vulgaris L. and Prunella grandiflora L. in different tumor cells.

ŞAHİN S., TEZCAN G., DEMİR C., TUNCA B., ÇEÇENER G., EGELİ Ü.

Trakya University Journal of Natural Sciences , vol.18, no.1, pp.9-13, 2017 (Peer-Reviewed Journal)

Aile Öyküsü Bulunan Polipozis Koli Tanılı vakalarda APC gen mutasyonlarının önemi

AK S., TUNCA B., YILMAZLAR A. T., ÖZTÜRK E., zorluoğlu a., IŞIK Ö., et al.

Journal of Disease of the Colon and Rectum , 2017 (Peer-Reviewed Journal)

Kolorektal Adenokarsinomlarda MACC1’ in invazyon üzerine etkisi

AKSOY F., UĞRAŞ N., YERCİ Ö., AK S., TUNCA B., ÖZTÜRK E., et al.

Journal of Disease of th Colon and Rectum , 2017 (Peer-Reviewed Journal)

In Vitro Cytotoxic Effect Evaluation of Dioscorea communis (L.) Caddick Wilkin Rhizome and Stem Extracts on Hepatocellular Carcinoma Cells

EGELİ Ü., YURDACAN B., HURİYET H., GÜNEY G., ERYILMAZ I. E., ÇAVAŞ T., et al.

Proceedings , vol.1, no.10, pp.1011, 2017 (Peer-Reviewed Journal)

Sporadik Kolorektal Kanserlerde MSI

AK S., TUNCA B., ÖZTÜRK E., YILMAZLAR A. T., YERCİ Ö., AKSOY F., et al.

Journal of Disease of the Colon and Rectum , 2017 (Peer-Reviewed Journal) Sustainable Development

CYTOTOXIC ACTIVITY OF ROSMARINIC ACID ISOLATED FROMPrunella vulgaris L. AND Prunella grandiflora L.IN DIFFERENT TUMOR CELLS

ŞAHİN S., tezcan G., DEMİR C., TUNCA B., ÇEÇENER G., EGELİ Ü.

trakya university journal of natural sciences , vol.18, no.1, pp.9-13, 2017 (Peer-Reviewed Journal)

The Cytotoxic and Apoptotic Effects of Usnic Acid on Prostate Cancer versus Normal Cells

ERYILMAZ I. E., GÜNEY G., YURDACAN B., EGELİ Ü., ÇEÇENER G., TUNCA B.

Proceedings , vol.1, no.10, pp.1027, 2017 (Peer-Reviewed Journal) Sustainable Development

Investigation of Apoptotic Effects of Usnic Acid on Hepatocellular Carcinoma

YURDACAN B., EGELİ Ü., GÜNEY G., ERYILMAZ I. E., ÇEÇENER G., TUNCA B.

Proceedings , vol.1, no.10, pp.1010, 2017 (Peer-Reviewed Journal)

Biomarker Potential of Urine miR-451 at Different Stages of Diabetic Nephropathy

Sayilar E. I., Güllülü M., Tuncel E., Peynirci H., Alemdar A., Tunca B., et al.

JOURNAL OF DIABETES & METABOLISM , vol.7, no.2, 2016 (ESCI) Sustainable Development

The effect of solid lipid nanoparticles on tamoxifen-resistant breast cancer cells

Eskiler G. G., ÇEÇENER G., Dikmen G., Genc L., EGELİ Ü.

International Journal of Pharmacy and Pharmaceutical Sciences , vol.8, pp.43-46, 2016 (Scopus) Sustainable Development

Effects of EGFR, CK19, CK20 and Survinin gene expression on radiotherapy results in patients with locally advanced head and neck cancer.

Kekilli K. E., DEMİRÖZ ABAKAY C., TEZCAN G., TUNCA B., EGELİ Ü., SARAYDAROĞLU Ö., et al.

Asian Pacific Journal Of Cancer Prevention , vol.16, no.7, pp.3023-7, 2015 (Scopus) Sustainable Development

Papers Presented at Peer-Reviewed Scientific Conferences 217

Antioksidan Özelliği Bulunan Rosmarinik Asitin Antikanser Özelliklerinin İncelenmesi.

Yüksel Ç., Şahin S., Tezcan G., Demir C., Tunca B., Çeçener G., et al.

Uludağ Üniversitesi IV. Bilgilendirme ve ARGE günleri, Bursa, Turkey, 11 - 13 November 2014, (Unpublished) Sustainable Development

The Biomarker Potential of Serum-Derived Exosomes Carrying Autophagic Regulators in Carotid Artery Stenosis Patients

Colakoglu Bergel C., Eryılmaz I. E., Arıöz B., Egeli Ü., Yolgösteren A., Erdemli Gürsel B., et al.

MECC Conference, Antalya, Turkey, 21 - 24 November 2024, pp.27, (Summary Text) Sustainable Development

The effect of BRAF inhibitor Encorafenib on cell migration and invasion ability in the BRAF-mutant metastatic castration-resistant prostate cancer cells

Eryılmaz I. E., Çolakoğlu Bergel C., Arıöz B., Egeli Ü.

16th European Multidisciplinary Congress on Urological Cancers (EMUC2024), Lisbon, Portugal, 7 - 10 November 2024, vol.69, pp.177, (Summary Text) Sustainable Development

CRISPR-Cas9-Mediated WBP2 Knockout Modulates Tamoxifen Resistance Estrogen Receptor Positive Breast Cancer Cells via the Hippo Pathway

Bulut E., Çeçener G., Huriyet N., Balaban R. F., Gökgöz M. Ş., Öztürk Nazlıoğlu H., et al.

CRISPRMED24, Kobenhavn, Denmark, 23 - 25 April 2024, pp.44, (Summary Text) Sustainable Development

120P Circulating exosomal biomarkers as a predictive and prognostic marker in non-metastatic-treated NSCLC

Bulut E., Coşkun A., Huriyet N., Balaban R. F., Çubukçu E., Egeli Ü., et al.

European Lung Cancer Congress 2024, Praha, Czech Republic, 20 - 23 March 2024, pp.6, (Summary Text) Sustainable Development

The role of WWOX tumor suppressor gene in the regulation of EMT process in breast cancer tamoxifen resistance

Bulut E., Küpeli P., Huriyet N., Topuz B., Balaban R. F., Tezcan Ünlü H., et al.

EACR The Tumour Ecosystem: Cellular Interactions and Therapeutic Opportunities, Bergamo, Italy, 19 - 21 March 2024 Sustainable Development

Luteolin disrupts cell health as a pro-oxidant agent against PC-3 metastatic castration-resistant prostate cancer cells

Eryılmaz I. E., Çolakoğlu Bergel C., Huriyet N., Arıöz B., Çeçener G., Egeli Ü.

9th BAU Drug Design Congress, İstanbul, Turkey, 29 November - 02 December 2023, pp.124, (Summary Text) Sustainable Development

Decoding the Transcriptome for the Ulcerated Plaque Discrimination in Carotid Artery Stenosis

Çolakoğlu Bergel C., Eryılmaz I. E., Yolgösteren A., Egeli Ü., Koşukcu C., Erdemli Gürsel B., et al.

24th Congress of Asian Society for Vascular Surgery (ASVS), Antalya, Turkey, 30 November - 03 December 2023, pp.1, (Summary Text) Sustainable Development

Evaluation of Potential Anticarcinogenic Effects of Liposomal Prodrug SN38-Oleic Acid on Triple Negative Breast Cancer Cells

Balaban R., Çeçener G., Patır İ., Şahin S., Haliç Poslu A., Koz G., et al.

Cellular Bases for Patient Response to Cancer Therapies, Lyon, France, 14 - 16 November 2023, pp.3, (Summary Text)

Asemptomatik karotis arter stenozlu hastaların düzgün ve ülsere plak materyallerinde karşılaştırmalı RNA-Seq analizi

Eryılmaz I. E., Çolakoğlu Bergel C., Yolgösteren A., Egeli Ü., Koşukçu C., Erdemli Gürsel B., et al.

18. Tıbbi Biyoloji ve Genetik Kongresi , Ankara, Turkey, 26 - 29 October 2023, pp.1-2, (Summary Text) Sustainable Development

Hormona duyarlı AR pozitif prostat kanserinde yeni nesil taksan-bazlı kemoterapinin in vitro anti-androjenik etkileri

Tezcan Ünlü H., Çeçener G., Egeli Ü.

16. Üroonkoloji Kongresi , Antalya, Turkey, 8 - 12 November 2023, pp.1-2, (Summary Text) Sustainable Development

Prostat kanserinde Cabazitaxel ile uyarılan hücresel oksidatif hasarın arttırılmasında üsnik asitin rolü

Çolakoğlu Bergel C., Eryılmaz I. E., Bulut E., Balaban R., Çeçener G., Egeli Ü.

16. Üroonkoloji Kongresi , Antalya, Turkey, 8 - 12 November 2023, pp.1-2, (Summary Text) Sustainable Development

AmpliSeq Transcriptome Profiling of Carotid Atherosclerotic Plaques: Comparative Analysis Between Asymptomatic and Symptomatic Patients

Çolakoğlu Bergel C., Eryılmaz I. E., Yolgösteren A., Egeli Ü., Erdemli Gürsel B., Biçer M., et al.

19th International Congress of Update in Cardiology and Cardiovascular Surgery, İstanbul, Turkey, 4 - 06 November 2023, pp.1-2, (Summary Text) Sustainable Development

Investigation of the synergistic effects of remdesivir and quercetin combination in triple negative breast cancer cells

Bulut E., Karabulut M., Çolakoğlu Bergel C., Egeli Ü., Çeçener G.

18. Ulusal Tıbbi Biyoloji Kongresi, Ankara, Turkey, 26 - 29 October 2023, pp.93, (Summary Text)

4-hydroxytamoxifen-loaded exosomes derived from mesenchymal stem cells play a role in the inhibition of the PI3K/MAPK and hippo pathways in tamoxifen-resistant MCF 7-TAM1 breast cancer cells

Tezcan Ünlü H., Çeçener G., Ünal U., Sağraç D., Kırbaş O. K., Taşlı P. N., et al.

18. Ulusal Tıbbi Biyoloji Kongresi, Ankara, Turkey, 26 - 29 October 2023, pp.16, (Summary Text) Sustainable Development

The role of the WWOX gene and its association with the hippo signaling pathway in tamoxifen resistance

Bulut E., Çeçener G., Gökgöz M. Ş., Özkaya G., Öztürk Nazlıoğlu H., Egeli Ü.

18. Tıbbi Biyoloji ve Genetik Kongresi, Ankara, Turkey, 26 - 29 October 2023, pp.76, (Summary Text) Sustainable Development

Düzgün ve Ülsere Plaklı Asemptomatik Karotis Arter Stenozu Hastalarının Ayırt Edilmesinde Anjiyogenez İlişkili Gen Ekspresyon Düzeylerinin Rolü

Çolakoğlu Bergel C., Eryılmaz I. E., Yolgösteren A., Egeli Ü., Arıöz B., Erdemli Gürsel B., et al.

21. Ulusal Hipertansiyon ve Kardiyovasküler Hastalıklar Kongresi, İzmir, Turkey, 5 - 07 May 2023, pp.22-23, (Summary Text) Sustainable Development

MULTİPL SKLEROZ TANILI HASTALARDA, FOKI (RS225870), TAQI (RS7975232) VE APAI (RS7975232) VİTAMİN D RESEPTÖRÜ (VDR) GEN POLİMORFİZMLERİNİN İNCELENMESİ

Tezcan Ünlü H., Sarıdaş F., Topuz B., Ünal U., Çeçener G., Taşkapılıoğlu Ö., et al.

18. Uludağ Nöroloji Günleri, Bursa, Turkey, 9 - 12 March 2023, pp.39-40, (Summary Text)

Multipl Skleroz Tanılı Hastalarda, FokI (rs225870), TaqI (rs7975232) ve ApaI (rs7975232) Vitamin D Reseptörü (VDR) Gen Polimorfizmlerinin İncelenmesi

Tezcan Ünlü H., Sarıdaş F., Topuz B., Ünal U., Çeçener G., Taşkapılıoğlu Ö., et al.

18. ULUDAĞ NÖROLOJİ GÜNLERİ, Bursa, Turkey, 09 March 2023, (Full Text) Sustainable Development

Investigation of the Effect of miR -342 Loaded Exosomes Derived from Mesenchymal Stem Cells on Tamoxifen-Resistant Breast Cancer Cells

XXVII SCHOOL OF PURE AND APPLIED BIOPHYSICS Extracellular vesicles: from biophysical to translational challenges, Venice, Italy, 6 - 10 February 2023, pp.37, (Summary Text)

Evaluation of the inflammation-associated gene expression levels between the asymptomatic carotid artery stenosis patients with ulcerated and smooth plaques: A pilot study

Yolgösteren A., Çolakoğlu Bergel C., Eryılmaz I. E., Egeli Ü., Biçer M., Erdemli Gürsel B., et al.

18th International Congress of Update in Cardiology and Cardiovascular Surgery, Antalya, Turkey, 1 - 04 December 2022, pp.11-12, (Summary Text) Sustainable Development

EPİZODİK VE KRONİK MİGREN HASTALARİNDA SCN9A VE SCN10A GEN POLİMORFİZMLERİNİN MİGRENİN KLİNİK ÖZELLİKLERİ VE KRONİSİTE GELİŞİMİ ÜZERİNE ETKİLERİNİN DEĞERLENDİRİLMESİ

Kılıç E., Çolakoğlu Bergel C., Oğuz Akarsu E., Eryılmaz I. E., Erer Özbek Ç. S., Egeli Ü., et al.

58. Ulusal Nöroloji Kongresi (Uluslararası Katılımlı), Antalya, Turkey, 19 - 24 November 2022, pp.7-8, (Summary Text) Sustainable Development

Antiviral RdRp İnhibitörü Remdesivir’in Kanser Hücrelerinde Hücre Ölümü Üzerine Etkilerinin Araştırılması

Eryılmaz I. E., Çolakoğlu Bergel C., Egeli Ü., Çeçener G.

24. Ulusal Kanser Kongresi , Ankara, Turkey, 9 - 13 November 2022, pp.9-10, (Summary Text) Sustainable Development

MULTİPLE SKLEROZ GELİŞİMİNDE MİR-10A EKSPRESYON DEĞİŞİMİNİN ARAŞTIRILMASI

Sarıdaş F., Tezcan Ünlü H., Çeçener G., Egeli Ü., Tunca B., Zarifoğlu M., et al.

58. ULUSAL NÖROLOJİ KONGRESİ, Antalya, Turkey, 19 November 2022, pp.228, (Summary Text) Sustainable Development

ÜSNİK ASİTİN OTOFAJİK ETKİSİNİN MALİGN MELANOM HÜCRELERİNDE QRT-PCR İLE DEĞERLENDİRİLMESİ

Colakoglu Bergel C., Eryılmaz I. E., Egeli Ü., Çeçener G.

5. Uluslararası Tıp Bilimleri ve Multidisipliner Yaklaşımlar Kongresi, Bursa, Turkey, 8 - 09 October 2022, pp.417, (Summary Text) Sustainable Development

ÜSNİK ASİT VE CABAZİTAXEL’İN METASTATİK KASTRASYONA DİRENÇLİ PROSTAT KANSERİ HÜCRELERİNDE ANTİTÜMÖRAL KOMBİN ETKİLERİ

Colakoglu Bergel C., Eryılmaz I. E., Bulut E., Balaban R., Çeçener G., Egeli Ü.

5. Uluslararası Tıp Bilimleri ve Multidisipliner Yaklaşımlar Kongresi, Bursa, Turkey, 8 - 09 October 2022, pp.416, (Summary Text) Sustainable Development

Üçlü negatif meme kanseri moleküler alt tiplerinin belirlenmesine yönelik geliştirilen multi-gen paneli ile hedefe yönelik tedavi seçiminin değerlendirilmesi

Çeçener G., Bulut E., Balaban R. F., Huriyet N., Ünal U., Tezcan Ünlü H., et al.

16. Ulusal Meme Hastalıkları Kongresi , Girne, Cyprus (Kktc), 15 - 18 September 2022, pp.61, (Summary Text)

Lokal İleri Pankreatik Duktal Adenokarsinomalarda İn-vitro Teknikler ile Rezektabilite İçin Yeni Tedavi Modellerinin Geliştirilmesi

Aksoy F., Dündar H. Z., Aksoy S., Mutlu M., Tekin Ç., Tunca B., et al.

22. Ulusal Cerrahi Kongresi, Antalya, Turkey, 23 - 27 March 2022, (Summary Text) Sustainable Development

Hedefe yönelik tedavi seçimi için üçlü negatif meme kanseri alt tiplerinden luminal androjen reseptörü (LAR) alt tipinin belirlenmesi240

TEZCAN H., ÜNAL U., ÇEÇENER G., ÖZTÜRK NAZLIOĞLU H., EFENDİ ERDEM E., EGELİ Ü., et al.

17. TIBBİ BİYOLOJİ VE GENETİK KONGRESİ, Turkey, 28 - 29 October 2021

Cabazitaxel’in prostat kanserindeki apoptotik etkinliğinin prooksidan etkileri ile ilişkisi157

ERYILMAZ I. E., EGELİ Ü., ÇEÇENER G.

17. TIBBİ BİYOLOJİ VE GENETİK KONGRESİ, Turkey, 28 October 2021, vol.52, pp.157-158, (Summary Text)

Hedefe yönelik tedavi seçimi için üçlü negatif meme kanseri alt tiplerinden luminal androjen reseptörü (LAR) alt tipinin belirlenmesi

Tezcan Ünlü H., Ünal U., Çeçener G., Öztürk Nazlıoğlu H., Efendi Erdem E., Egeli Ü., et al.

XVII. Tıbbi Biyoloji ve Genetik Kongresi, İstanbul, Turkey, 28 - 31 October 2021, vol.52, no.1, pp.240-241, (Summary Text)

LOKAL İLERİ PROSTAT KANSERLERİNDE DE NOVO ANDROJEN RESEPTÖR VARYASYONLARININ INSILICO ANALİZLER İLE DEĞERLENDİRİLMESİ

Eryılmaz I. E., Aytaç Vuruşkan B., Kaygısız O., Çeçener G., Egeli Ü., Vuruşkan H.

15. Üroonkoloji Kongresi, Antalya, Turkey, 10 - 14 November 2021 Sustainable Development

Lokal ileri prostat kanserlerinde de novo androjen reseptör varyasyonlarının in silico analizler ile değerlendirilmesi

ERYILMAZ I. E., ÇEÇENER G., EGELİ Ü., AYTAÇ VURUŞKAN B., VURUŞKAN H., KAYGISIZ O.

15. Üroonkoloji Kongresi, Antalya, Turkey, 10 November 2021, (Summary Text)

Mide kanseri hücrelerinin agresifliğinin baskılanmasında Olea europaea yaprak ekstresi ile 5-fluorourasil ve cisplatin kombin tedavilerinin etkileri

Tekin Ç., Tunca B., Mutlu M., Aksoy S., Tezcan G., Budak F., et al.

XVII. Tıbbi Biyoloji ve Genetik Kongresi, 28 October 2021 Sustainable Development

Glioblastomada temozolomid tedavisine bağlı olarak kanser hücrelerinde gelişen yaşlanma sürecinde olea europaea yaprak özütünün koruyucu etkisi

Mutlu Erçelik M., Tunca B., Aksoy S., Tekin Ç., Egeli Ü., Çeçener G.

17. TIBBİ BİYOLOJİ VE GENETİK KONGRESİ, İstanbul, Turkey, 28 - 31 October 2021 Sustainable Development

Cabazitaxel’in prostat kanserindeki apoptotik etkinliğinin prooksidan etkileri ile ilişkisi

XVII. Tıbbi Biyoloji ve Genetik Kongresi, 28 - 31 October 2021, vol.52, pp.157-158, (Summary Text) Sustainable Development

Metastatik prostat kanseri için redoks adaptasyonu geliştirilmiş bir in vitro model oluşturulması ve karakterize edilmesi

XVII. Tıbbi Biyoloji ve Genetik Kongresi, 28 - 31 October 2021, vol.52, pp.155-156 Sustainable Development

METASTATİK PROSTAT KANSERİNDE CABAZİTAXEL ETKİNLİĞİNİ AZALTAN YENİ BİR MEKANİZMA:EDİNİLMİŞ REDOKS DİRENCİ

ERYILMAZ I. E., EGELİ Ü., ÇEÇENER G.

15. Üroonkoloji Kongresi, Antalya, Turkey, 10 - 14 November 2021, (Summary Text) Sustainable Development

The molecular consequences of the novel speckle-type POZ protein (SPOP) gene mutations at the protein level: A prostate cancer perspective

ERYILMAZ I. E., AYTAÇ VURUŞKAN B., KAYGISIZ O., ÇEÇENER G., EGELİ Ü., VURUŞKAN H.

European Human Genetics Virtual Conference, 28 August 2021, (Summary Text)

Nrf2-mediated Disruption of Redox Adaptation by Cabazitaxel in Metastatic Prostate Cancer

EACR 2021 Virtual Congress: Better Outcomes Through Research, United Kingdom, 09 June 2021, (Summary Text) Sustainable Development

Düşük ve Yüksek Dereceli Neoplazi Olarak Tanımlanan Kolorektal Poliplerin Prognozunda Etkili Olabilecek Moleküler Belirteçler Araştırılması

AKSOY F., YILMAZLAR A. T., IŞIK Ö., ÖZTÜRK E., AKSOY S., TUNCA B., et al.

XVII. Türk Kolon ve Rektum Cerrahi Kongresi, Antalya, Turkey, 9 - 13 April 2021, (Summary Text)

Berrak Hücreli Tip Renal Hücreli Karsinom Hastaları İçin Potansiyel Prognostik Biyobelirteç Olarak KAT5 Geni Ve Mir-22’Nin Değerlendirilmesi

ÜNAL U., Tezcan Ünlü H., ÇEÇENER G., Efendi Erdem E., EGELİ Ü., AYTAÇ VURUŞKAN B., et al.

8th Multidisciplinary Cancer Research Congress, Turkey, 16 January 2021, (Summary Text)

Berrak Hücreli Tip Renal Hücreli Karsinom Hastaları için Potansiyel Prognostik Biyobelirteç Olarak KAT5 Geni ve Mir‐22’nin Değerlendirilmesi.

Ünal U., Tezcan Ünlü H., Çeçener G., Efendi Erdem E., Aytaç Vuruşkan B., Egeli Ü., et al.

8.Multidisipliner Kanser Araştırma Kongresi , İstanbul, Turkey, 15 - 17 January 2021, pp.1, (Summary Text)

Trastuzumab ile tedavi edilen HER2 pozitif meme kanseri hastalarında PIK3CA mutasyonlarının ilaç yanıtı ile ilişkisinin değerlendirilmesi.

Huseynov F., Tezcan Ünlü H., Çeçener G., Egeli Ü.

II. Uluslararası Genç Araştırmacılar Öğrenci Kongresi (IYRSC 2020), Burdur, Turkey, 17 - 19 December 2020, pp.199, (Summary Text)

Trastuzumab ile Tedavi Edilen HER2 Pozitif Meme Kanseri Hastalarında PIK3CA Mutasyonlarının İlaç Yanıtı ile İlişkisinin Değerlendirilmesi

HUSEYNOV F., Tezcan Ünlü H., ÇEÇENER G., EGELİ Ü.

II. Uluslararası Genç Araştırmacılar Öğrenci Kongresi, Burdur, Turkey, 17 - 19 December 2020, (Summary Text)

Detection and analysis of circulating tumor cells in liquid biopsy from patients with liver tranplantation

Aksoy S., Aksoy F., Dündar H. Z., Mutlu M., Tekin Ç., Tunca B., et al.

55th Congress of the European Society for Surgical Research, Innsbruck, Austria, 10 - 11 December 2020, pp.95, (Summary Text)

The effect of olea europea leaf extract (OLE) on TMZ resistance mechanism

MUTLU M., TUNCA B., TEKİN C., AKSOY S., EGELİ Ü., ÇEÇENER G.

55th Congress of the European Society for Surgical Research the 44th Congress of the Austrian Society for Surgical Research, Innsbruck, Austria, 10 - 11 December 2020, (Summary Text)

Dysregulation of E-cadherin and twist expressions in gastric cancer

TEKİN C., MUTLU M., TUNCA B., AKSOY S., AKSOY F., CİVAN M. N., et al.

55th Congress of the European Society for Surgical Research the 44th Congress of the Austrian Society for Surgical Research, Innsbruck, Austria, 10 - 11 December 2020 Sustainable Development

Philadelphia Benzeri ALL Alt Grubunun Tanımlanması

EFENDİ E., ÇEÇENER G., SEZGİN EVİM M., TEZCAN ÜNLÜ H., ÜNAL U., BAYTAN B., et al.

7. Ulusal Pediatrik Hematoloji Sempozyumu 13-14 Kasım 2020, Turkey, 13 November 2020

Erken Başlangıçlı Alzheımer Hastalığı’nda Genetik Varyasyonların Klinik Fenotipe Etkileri: Uludağ Üniversitesi Deneyimi

ERYILMAZ I. E., BAKAR H. M., YURDACAN B., EGELİ Ü., ÇEÇENER G., ÇOLAK D. K., et al.

10. Ulusal Alzheimer Sanal Kongresi, Turkey, 5 - 08 November 2020

BİR UBİKUİTİN E3 LİGAZ OLAN SIAH1’xxİN YÜKSEK İFADESİ, MEME KANSERİNDE ÖSTROJEN RESEPTÖR POZİTİFLİĞİ İLE İLİŞKİLİDİR

Sabour Takanlou L., ÇEÇENER G., maryam S. T., tezcan h., ÖZTÜRK NAZLIOĞLU H., ÇUBUKÇU E., et al.

6. EGE HEMATOLOJİ ONKOLOJİ KONGRESİ, Turkey, 13 - 15 March 2020

BİR UBİKUİTİN E3 LİGAZ OLAN SIAH1'İN YÜKSEK İFADESİ, MEME KANSERİNDE ÖSTROJEN RESEPTÖR POZİTİFLİĞİ İLE İLİŞKİLİDİR

Sabour Takanlou L., ÇEÇENER G., Sabour Takanlou M., TEZCAN H., ÖZTÜRK NAZLIOĞLU H., ÇUBUKÇU E., et al.

6. EGE HEMATOLOJİ ONKOLOJİ KONGRESİ, İzmir, Turkey, 13 March 2020, (Summary Text)

İNVAZİV DUKTAL KARSİNOM TEŞHİSİ ALMIŞ MEME KANSERİ HASTALARINDA YAP VE TAZ GEN EKSPRESYONLARININ RETROSPEKTİF OLARAK ARAŞTIRILMASI

Sabour Takanlou M., ÇEÇENER G., Sabour Takanlou L., TEZCAN H., ÖZTÜRK NAZLIOĞLU H., ÇUBUKÇU E., et al.

6. EGE HEMATOLOJİ ONKOLOJİ KONGRESİ, İzmir, Turkey, 13 March 2020 Sustainable Development

Transcriptional regulation of RNAs in androgen receptor axis by apigenin compared to cabazitaxel efficiency in prostate cancer cells

ERYILMAZ I. E., EGELİ Ü., ÇEÇENER G., TUNCA B.

11th European Multidisciplinary Meeting on Urological Cancers (EMUC), 13 - 17 November 2019, vol.18, pp.3487, (Summary Text) Sustainable Development

LOKAL İLERİ PROSTAT KANSERLERİNDE SPINK1 EKSPRESYON ARTIŞININ BİYOKİMYASAL REKÜRRENS İLE İLİŞKİSİ

ERYILMAZ I. E., KAYGISIZ O., ÇEÇENER G., AYTAÇ VURUŞKAN B., EGELİ Ü., TUNCA B., et al.

14th International Urooncology Congress, Antalya, Turkey, 6 - 10 November 2019, pp.27, (Summary Text) Sustainable Development

Alfa talaseminin moleküler tanısında direkt sekans yöntemi: revize metodoloji

ERYILMAZ I. E., baytan b., ünal u., efendi e., tezcan h., ÇEÇENER G., et al.

16. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Turkey, 27 - 30 October 2019

Dopamin β-hidroksilaz enziminin erken başlangıçlı Parkinson hastalığına yatkınlıkla ilişkisinin değerlendirilmesi

ERYILMAZ I. E., ERER ÖZBEK Ç. S., ÇOLAK D. K., ZARİFOĞLU M., EGELİ Ü., ÇEÇENER G., et al.

16. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Turkey, 27 - 30 October 2019

Lokal ileri prostat kanserlerinde novel Speckle-type POZ Protein (SPOP) mutasyonları

ERYILMAZ I. E., KAYGISIZ O., ÇEÇENER G., AYTAÇ VURUŞKAN B., EGELİ Ü., TUNCA B., et al.

16. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Turkey, 27 - 30 October 2019, (Summary Text) Sustainable Development

Inula Viscosa Bitkisinin Metanol Özütünün Malign Melanom Hücre Hattındaki Antitümöral ve Sitotoksik Etkisinin Araştırılması

Koçak D. K., Egeli Ü., Eryılmaz I. E., Aybastıer Ö., Malyer H., Çeçener G., et al.

16. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Muğla, Turkey, 27 - 30 October 2019, (Summary Text)

Olea europaea Yaprak Özütünün (OLE)Glioblastoma Hücrelerinde Mezenkimal GeçişMekanizması Üzerindeki Etkisi

Mutlu M., TUNCA B., AKSOY S., Çağla T., EGELİ Ü., ÇEÇENER G.

16. Yıbbi Biyoloji ve Genetik Kongresi, Turkey, 27 - 30 October 2019

Mide Kanserinde Olea europaea YaprakÖzütünün (OLE) Sitotoksik ve AntiinvazivEtkisinin in-vitro Analizler ile Belirlenmesi

Tekin Ç., TUNCA B., AKSOY S., Mutlu M., ÇEÇENER G., EGELİ Ü.

16. Tıbbi Biyoloji ve Genetik Kongresi, Turkey, 27 - 30 October 2019, (Summary Text) Sustainable Development

Olea europaea Yaprak Özütünün (OLE)Glioblastoma Hücrelerinin Agresifliği ÜzerineEtkilerinin 3 Boyutlu Tümör ModelindeGösterilmesi

Mutlu M., TUNCA B., AKSOY S., Çağla T., EGELİ Ü., ÇEÇENER G.

16. Tıbbi Biyoloji ve Genetik Kongresi, Turkey, 27 - 30 October 2019, (Summary Text)

Pediatrik glioblastomalarda TERT promotorbölge mutasyonları

Civan N., Melis M., Çağla T., TAŞKAPILIOĞLU M. Ö., KAYA İ. S., AKSOY S., et al.

16. Tıbbi Biyoloji ve Genetik Kongresi, Turkey, 27 - 30 October 2019

Investigation of Expression Levels of VHL, HIF1A and KAT 5 Genes in Clear Cell Renal Cell Carcinoma

Ünal U., ÇEÇENER G., AYTAÇ VURUŞKAN B., tezcan h., Efendi E., EGELİ Ü., et al.

16. TIBBİ BİYOLOJİ ve GENETİK KONGRESİ, 27 - 30 October 2019, (Summary Text)

Türk Pediatrik Akut Lenfoblastik Lösemi Vakalarında Philadelphia Benzeri Alt Grubun Tanımlanması

Efendi E., ÇEÇENER G., baytan b., EGELİ Ü., TUNCA B., Ünal U., et al.

XVI. TIBBİ BİYOLOJİ ve GENETİK KONGRESİ, 27 - 30 October 2019, (Summary Text)

mikroRNA-216b, KRAS 3’UTR Bölgesini Hedefleyerek MemeKanseri Hücrelerinin Büyümesini İnhibe Eder

tezcan h., ÇEÇENER G., TAŞAR P., EGELİ Ü., TUNCA B., GÖKGÖZ M. Ş.

16. Tıbbi Biyoloji ve Genetik Kongresi, 27 - 30 October 2019, (Summary Text)

MACC1, NM-23H1, MALAT1 ve PTENP1Belirteçleri Kullanılarak Adjuvan TedaviyeYönlendirilecek Kolon Tümörlerinin TedaviyeVerecekleri Cevabın İlaç Direnç ModelindeGösterilmesi

AKSOY S., TUNCA B., Mutlu M., ÇEÇENER G., EGELİ Ü.

16. Tıbbi Biyoloji ve Genetik Kongresi, Turkey, 27 - 30 October 2019, (Summary Text)

UNREZEKTABL PANKREAS KANSERLERİNDE OLE’NİN OPERABİLİTE ÜZERİNE ETKİSİNİN ÜÇ BOYUTLU KÜLTÜR İLE GÖSTERİLMESİ

AKSOY F., Tekin Ç., Mutlu M., AKSOY S., TUNCA B., DÜNDAR H. Z., et al.

14. Hepato Pankreato Bilier Cerrahi Kongresi, Turkey, 23 - 26 October 2019 Sustainable Development

PANKREAS KANSERLERİNDE LİKİT BİYOPSİ İLE SAPTANAN SİRKÜLE KANSER HÜCRELERİNİN SAĞ KALIMI BELİRLEMEDEKİ ROLLERİ

AKSOY S., AKSOY F., Mutlu M., Tekin Ç., TUNCA B., DÜNDAR H. Z., et al.

14. Hepato Pankreato Bilier Cerrahi Kongresi, Turkey, 23 - 26 October 2019 Sustainable Development

Unrezektabl Pankreas Kanserlerinde Ole’nin Operabilite Üzerine Etkisinin Üç Boyutlu Kültür İle Gösterilmesi.

AKSOY F., TEKİN Ç., MUTLU M., AK AKSOY S., TUNCA B., DÜNDAR H. Z., et al.

14. Türk Hepato Pankreato Bilier Cerrahi Kongresi. Antalya 2019, Antalya, Turkey, 23 - 26 October 2019, (Summary Text) Sustainable Development

Pankreas Kanserlerinde Likit Biyopsi İle Saptanan Sirküle Kanser Hücrelerinin Sağ Kalımı Belirlemedeki Rolleri

AK AKSOY S., AKSOY F., MUTLU M., TEKİN Ç., TUNCA B., DÜNDAR H. Z., et al.

14. Türk Hepato Pankreato Bilier Cerrahi Kongresi. Antalya 2019, Antalya, Turkey, 23 - 26 October 2019 Sustainable Development

THE EXPRESSION STATUS OF CANCER STEM CELLMARKERS MAY PREDICT POOR PROGNOSIS INPATIENTS UNDERGOING LIVER TRANSPLANTATIONFOR HEPATOCELLULAR CARCINOMA

AKSOY F., DÜNDAR H. Z., AKSOY S., TUNCA B., TAŞAR P., UĞRAŞ N., et al.

19th Congress of the European Society for Organ Transplantation, 15 - 18 September 2019, (Summary Text) Sustainable Development

RECURRENT HEPATOCELLULAR CARCINOMA AFTERLIVER TRANSPLANTATION: IDENTIFYING THE HIGHRISKPATIENT USING THE EXPRESSION PROFILES OFEMT-ASSOCIATED LNCRNAS

AKSOY S., AKSOY F., DÜNDAR H. Z., TUNCA B., TAŞAR P., UĞRAŞ N., et al.

19th Congress of the European Society for Organ Transplantation, 15 - 18 September 2019

TAMOKSİFEN TEDAVİSİ ALAN MEME KANSERLİ HASTALARDA CYP2D6 POLİMORFİZMLERİNİN TEDAVİ YANITINA ETKİSİ

sabour m., sabour l., ÇEÇENER G., tezcan h., TEZCAN G., EGELİ Ü., et al.

15. ULUSAL MEME HASTALIKLARI KONGRESİ, Turkey, 17 - 20 October 2019, (Summary Text) Sustainable Development

Long noncoding RNA BANCR predicts poor clinical outcome in Periampullary Tumors.

AKSOY F., DÜNDAR H. Z., AK S., TUNCA B., TAŞAR P., ÖZEN Y., et al.

3rd International Advanced Liver Pancreas Surgery Symposium . ISLS 2019, İstanbul, Turkey, 10 - 12 October 2019, (Summary Text)

A Novel Strategy for Treatment of Unresecrable Locally Advanced Pancreatic Cancer

AKSOY S., TUNCA B., MUTLU M., TEKİN Ç., AKSOY F., DÜNDAR H. Z., et al.

3rd International Advanced Liver & Pancreas Surgery Syposium, 10 October 2019, (Full Text) Sustainable Development

A novel strategy for treatment of Unresectable Locally Advanced Pancreatic Cancer.

AK S., TUNCA B., MUTLU M., TEKİN Ç., AKSOY F., DÜNDAR H. Z., et al.

3rd International Advanced Liver Pancreas Surgery Symposium . ISLS 2019, İstanbul, Turkey, 10 - 12 October 2019, (Summary Text) Sustainable Development

A Family with Early-Onset Familial Alzheimer Disease accompanied by germline PSEN2 mutations

Yurdacan B., Eryılmaz I. E., Egeli Ü., Bakar H. M., Çeçener G., Tunca B.

FENS Regional Meeting 2019, Belgrade, Serbia, 10 - 13 July 2019, (Summary Text)

Combination treatment of usnic acid and sorafenib on hepatocellular carcinoma

YURDACAN B., EGELİ Ü., GÜNEY ESKİLER G., ERYILMAZ I. E., ÇEÇENER G., TUNCA B.

Erciyes Tıp Genetik Günleri 2019, Turkey, 21 - 23 February 2019

MicroRNA-let-7a functions as a tumor suppressor and inhibits cancer stem cell growth in triple negative breast cancer by targeting PIK3CA

TEZCAN H., ÇEÇENER G., EGELİ Ü., TUNCA B.

3. Uluslararası Katılımlı Kök Hücre ve Hücresel Tedaviler Kongresi “Joint Meeting With ISSCA”, İstanbul, Turkey, 12 April - 14 February 2019, (Summary Text) Sustainable Development

Triple Negatif Meme Kanserinde Talazoparib Direnci: MikroRNA Ekspresyon Profili

23. Ulusal Kanser Kongresi, Turkey, 17 - 21 April 2019, (Summary Text) Sustainable Development

Prognostic Factors In Colorectal Carcinomas Arising In Polyps: The ExpressionProfiles Of Lncrnas

AKSOY S., IŞIK Ö., AKSOY F., YILMAZLAR A. T., TUNCA B., ÖZTÜRK E., et al.

THE 54TH CONGRESS OF THE EUROPEAN SOCIETY FOR SURGICAL RESEARCH, 13 - 15 March 2019

Kolon Tümörlerinin Prognozunu Belirlemede MiRNA’ Ların Kullanımı

AKSOY S., IŞIK Ö., AKSOY F., TUNCA B., YILMAZLAR A. T., ÖZTÜRK E., et al.

8. Uludağ Genel Cerrahide Güncel Yaklaşımlar Toplantısı, Bursa, Turkey, 15 - 17 March 2019

Circulating Mir-10B is Assosiated with Overall Survival in Pancreatic Ductal Adenocarcinoma.

AKSOY F., AK S., DÜNDAR H. Z., TAŞAR P., TUNCA B., EGELİ Ü., et al.

54th Congress of the European Society for Surgical Research., CENEVRE, Switzerland, 14 - 15 March 2019, (Summary Text)

The Role Of Rna-Based Markers On Hepatotropic Viruses Related-HepatocellularCarcinoma Recurrence After Liver Transplantation

AKSOY F., AKSOY S., DÜNDAR H. Z., TUNCA B., TAŞAR P., UĞRAŞ N., et al.

THE 54TH CONGRESS OF THE EUROPEAN SOCIETY FOR SURGICAL RESEARCH, 13 - 15 March 2019

Analysis Of Microsatellite Instability Status And Mismatch Repair Gene MutationsIn Turkish Patients With Lynch Syndrome

AKSOY S., TUNCA B., YILMAZLAR A. T., IŞIK Ö., EGELİ Ü., ÇEÇENER G., et al.

THE 54TH CONGRESS OF THE EUROPEAN SOCIETY FOR SURGICAL RESEARCH, 13 - 15 March 2019

Primer Glioblastoma Tümörlerinde Kodlama Yapmayan RNA MALAT1’in Prognostik Öneminin Araştırılması

MUTLU M., AKSOY S., TUNCA B., KOCAELİ H., BEKAR A., CİVAN M. N., et al.

Yeditepe Üniversitesi 6.Ulusal Genetik ve Biyomühendislik Günleri Kanser ve Kök Hücre Kongresi, Turkey, 16 February 2019

A synergistic apoptotic effect of combined treatment usnic acid with tamoxifen in breast cancer

GÜNEY G., ERYILMAZ I. E., YURDACAN B., EGELİ Ü., ÇEÇENER G., TUNCA B.

6th International BAU Drug Design Congress, 13 - 15 December 2018, (Summary Text) Sustainable Development

The role of multidrug resistance in PARP inhibitor-resistant triple negative breast cancer cells

6th International BAU Drug Design Congress, 13 - 15 December 2018, (Summary Text) Sustainable Development

The potentials of AR, AR-regulated TMPRSS2-ERG fusion and KLK3 mRNAs for prostate cancer risk assessment in suspicious prostate biopsy cores with atypical small acinar proliferation

ERYILMAZ I. E., KAYGISIZ O., AYTAÇ VURUŞKAN B., EGELİ Ü., TUNCA B., KORDAN Y., et al.

10th European Multidisciplinary Congress on Urological Cancers, Amsterdam, Netherlands, 8 - 11 November 2018, vol.17, pp.2889, (Summary Text) Sustainable Development

Radikal prostatektomi uygulanan lokal ileri prostat kanserlerinde TMPRSS2-ERG füzyonu ve KLK3 mRNA seviyesinin biyokimyasal rekürrens ile ilişkisi: İlk sonuçlarımız

KAYGISIZ O., ERYILMAZ I. E., AYTAÇ VURUŞKAN B., EGELİ Ü., VURUŞKAN H., TUNCA B., et al.

4. Ulusal Ürolojik Cerrahi Kongresi, Antalya, Turkey, 31 October - 04 November 2018, (Summary Text) Sustainable Development

Cancer stem cell markers in pancreatic ductal adenocarcinoma

Aksoy F., Kaya E., Egeli Ü., Dundar H. Z., Tasar P., Aksoy S. A., et al.

43rd ESMO Congress (ESMO), Munich, Germany, 19 - 23 October 2018, vol.29 Sustainable Development

Synthetic lethal effects of BMN 673 loaded solid lipid nanoparticles on triple-negative breast cance

MAP 2018 – Molecular Analysis for Personalised Therapy, 14 - 15 September 2018

Association BRCA mutation status between BMN 673 (talazoparib), an oral PARP inhibitor, in triple-negative breast cancer

Eskiler G. G., Cecener G., Egeli Ü., Tunca B.

Conference on Molecular Analysis for Personalised Therapy (MAP), Paris, France, 14 - 15 September 2018, vol.29 Sustainable Development

Synthetic lethal effects of BMN 673 loaded solid lipid nanoparticles on triple-negative breast cancer

Eskiler G. G., Cecener G., Egeli Ü., Tunca B.

Conference on Molecular Analysis for Personalised Therapy (MAP), Paris, France, 14 - 15 September 2018, vol.29, (Summary Text) Sustainable Development

A novel Zn(II) complex loaded solid lipid nanoparticles for breast cancer treatment: Synthesis, characterization and cytotoxic studies

GÜNEY G., ÇEÇENER G., KANİ İ., DİKMEN G., EGELİ Ü., TUNCA B.

NANO-2018, 27 - 30 August 2018, (Summary Text) Sustainable Development

A novel Zn (II) complex

GÜNEY G., ÇEÇENER G., KANİ İ., DİKMEN G., EGELİ Ü., TUNCA B.

NANO-2018, 27 - 30 August 2018

Therapeutic potential of BMN 673 loaded solid lipid nanoparticles in triple negative breast cancer

NANO-2018, Ukraine, 27 - 30 August 2018, (Summary Text) Sustainable Development

APC Mutasyonu Olmayan Polipozis Koli Tanılı Vakalarda Yeni Diagnostik Belirteçler

AKSOY F., AK S., IŞIK Ö., TUNCA B., YILMAZLAR A. T., ÖZTÜRK E., et al.

21. Ulusal Cerrahi Kongresi, Turkey, 11 - 15 April 2018

MALAT1: T2-3 nod negatif kolon kanserinde adjuvan tedavi kararını belirlemede etkili bir belirteç

AK S., TUNCA B., ÖZTÜRK E., YILMAZLAR A. T., IŞIK Ö., UĞRAŞ N., et al.

21. Ulusal Cerrahi Kongresi, Turkey, 11 - 15 April 2018, (Summary Text) Sustainable Development

Pankreatik Duktal Adenokarsinomlarda Preoperatif Dönemde miRNA’ ların Tanısal Belirteç Olarak Kullanımı

AK S., AKSOY F., TUNCA B., DÜNDAR H. Z., TAŞAR P., ÖZEN Y., et al.

21. Ulusal Cerrahi Kongresi, Turkey, 11 - 15 April 2018

In Vitro Proliferative and Adhesive Properties of Human Dermal Fibroblasts on Electrospun Poly(ε-caprolactone) Scaffolds

TEZCAN H., ERYILMAZ I. E., DÜZYER Ş., KORAL KOÇ S., ÇEÇENER G., EGELİ Ü., et al.

4th INTERNATIONAL CONGRESS ON APPLIED BIOLOGICAL SCIENCES, 3 - 05 May 2018, (Summary Text)

Promising anticancer effects of usnic acid in breast cancer

GÜNEY G., ERYILMAZ I. E., EGELİ Ü., YURDACAN B., ÇEÇENER G., TUNCA B.

International Congress for Applied Biological Sciences (ICABS 2018), 3 - 05 May 2018, (Summary Text) Sustainable Development

Evaluation of combined antitumoral effect of usnic acid and MDV3100 (Enzalutamide) on hormone-dependent prostate cancer cells

ERYILMAZ I. E., GÜNEY G., EGELİ Ü., YURDACAN B., ÇEÇENER G., TUNCA B.

IV. International Congress for Applied Biological Sciences (ICABS 2018), 3 - 05 May 2018, (Summary Text) Sustainable Development

Tamoxifen loaded solid lipid nanoparticles in reversing of tamoxifen-resistance: microRNA expression profiles

IV. International Congress for Applied Biological Sciences (ICABS 2018), 3 - 05 May 2018

Effect of electrospun PCL nanofibrous scaffolds on the in vitro proliferation of human primary dermal fibroblasts

ERYILMAZ I. E., tezcan h., DÜZYER Ş., KORAL KOÇ S., ÇEÇENER G., HOCKENBERGER A., et al.

4th INTERNATIONAL CONGRESS ON APPLIED BIOLOGICAL SCIENCES, 3 - 05 May 2018, (Summary Text)

POSTER_Effect of Electrospun PCL Nanofibrous Scaffolds on the in vitro Proliferation of Human Primary Dermal Fibroblasts

ERYILMAZ I. E., TEZCAN H., DÜZYER GEBİZLİ Ş., KORAL KOÇ S., ÇEÇENER G., HOCKENBERGER A., et al.

4th International Congress on Applied Biological Sciences (ICABS2018), Eskişehir, Turkey, 3 - 05 May 2018

In vitro proliferative and adhesive properties of human dermal fibroblasts on electrospun poly(ε-caprolactone)scaffolds

Tezcan H., ERYILMAZ I. E., DÜZYER GEBİZLİ Ş., KORAL KOÇ S., ÇEÇENER G., EGELİ Ü., et al.

4th International Congress on Applied Biological Sciences, 3 - 05 May 2018

Periampuller Bölge Tümörlerinde Primer Lokalizasyonun KRAS Mutasyonları İle Belirlenmesi.

AK S., AKSOY F., TUNCA B., DÜNDAR H. Z., TAŞAR P., YERCİ Ö., et al.

21. Ulusal Cerrahi Kongresi. Antalya 2018, Antalya, Turkey, 11 - 15 April 2018

DPYD IVS141GA Variantı Olan İleri Evre Kolorektal Kanser Hastalarında 5-FU’ya Bağlı Hematolojik Yan Etkiler

DELİGÖNÜL A., KANAT Ö., AK S., TEZCAN G., EVRENSEL T., TUNCA B., et al.

14. Uludağ İç Hastalıkları Kış Kongresi, 3. Bursa Aile Hekimliği Derneği Ulusal Kongresi, Turkey, 4 March - 07 April 2018 Sustainable Development

Pediatrik düşük dereceli gliomalarda kodlama yapmayan RNA’ların önemi

BALÇIN R. N., AK S., mutlu m., baş e. ı., TAŞKAPILIOĞLU M. Ö., TUNCA B., et al.

Türk Nöroşirurji Derneği 32. Bilimsel kongresi, Turkey, 20 - 24 April 2018

MicroRNA dysregulation as a prognostic biomarker in wild-type RAS/RAF/PTEN/PI3 metastatic colon cancer treated with anti-EGFRtherapeutics

AK S., TUNCA B., ERTAŞ H., UĞRAŞ N., ÖZTÜRK E., YILMAZLAR A. T., et al.

TAT 2018 – Targeted Anticancer Therapies, 5 - 07 March 2018 Sustainable Development

The clinical significance of lncRNA DANCR in upper rectaladenocarcinoma

AKSOY F., AK S., TUNCA B., IŞIK Ö., ÖZTÜRK E., YILMAZLAR A. T., et al.

TAT 2018 - Targeted Anticancer Therapies, 5 - 07 March 2018

DPYD IVS141GA Variantı Olan İleri Evre Kolorektal Kanser Hastalarında 5-FU’xxya Bağlı Hematolojik Yan Etkiler

DELİGÖNÜL A., KANAT Ö., AKSOY S., TEZCAN G., EVRENSEL T., TUNCA B., et al.

14. İÇ HASTALIKLARI KIŞ KONGRESİ, 3. BURSA AİLE HEKİMLİĞİ KONGRESİ, 8. ULUDAĞ HEMŞİREKİL KONGRESİ, Bursa, Turkey, 4 - 07 March 2018 Sustainable Development

MicroRNA dysregulation as a prognostic biomarker in wild-type RAS/RAF/PTEN/PI3 metastatic colon cancer treated with anti-EGFR therapeutics

Aksoy S., Kanat O., Tunca B., Ertas H., Ugras N., Ozturk E., et al.

International Congress on Targeted Anticancer Therapies (TAT), Paris, France, 5 - 07 March 2018, vol.29 Sustainable Development

The clinical significance of lncRNA DANCR in upper rectal adenocarcinoma

Aksoy F., Aksoy S., Tunca B., Isik Ö., Ozturk E., Yilmazlar T., et al.

International Congress on Targeted Anticancer Therapies (TAT), Paris, France, 5 - 07 March 2018

MicroRNA-21 functions as a prognosis predictor in head of pancreas tumor

Aksoy F., Aksoy S., Tunca B., Dundar H. Z., Sarkut P., Ozen Y., et al.

International Congress on Targeted Anticancer Therapies (TAT), Paris, France, 5 - 07 March 2018, vol.29

MikroRNA 10b’nin Yüksek Ekspresyonu Pankreatik Duktal Adenokarsinomlarda Bağımsız Bir Prognostik Parametredir.

AK S., AKSOY F., TUNCA B., EGELİ Ü., ÇEÇENER G., DÜNDAR H. Z., et al.

13. Hepatopankreatobilier Cerrahi Kongresi. Antalya 2017, Antalya, Turkey, 1 - 04 November 2017, (Summary Text)

MikroRNA lOb’xxnin yuksek ekspresyonu pankreatik duktal adenokarsinomlarda bagimsiz bir prognostik parametredir

AK S., AKSOY F., TUNCA B., EGELİ Ü., ÇEÇENER G., DÜNDAR H. Z., et al.

13.Hepatopankreatikobilier cerrahi kongresi, Turkey, 1 - 04 November 2017, (Summary Text)

Potential role of solid lipid nanoparticles in overcoming the acquired tamoxifen resistance of breast cancer

ÇEÇENER G., Eskiler G. G., EGELİ Ü., TUNCA B.

European Biotechnology Congress, Dubrovnik, Croatia, 25 - 27 May 2017, vol.256, (Summary Text) Sustainable Development

Long non coding RNA BCAR4 act as an oncogene in rectum adenocarcinoma

AKSOY F., AK S., TUNCA B., ÖZTÜRK E., YILMAZLAR A. T., UĞRAŞ N., et al.

EACR-AACR-SIC SPECIAL CONFERENCE 2017The Challenges of Optimising Immuno and Targeted TherapiesFrom Cancer Biology to the Clinic, 24 - 27 June 2017

The over expression of HULC is associated with tumorigenesis of colorectal cancer patients

AK S., TUNCA B., ÖZTÜRK E., YILMAZLAR A. T., UĞRAŞ N., YERCİ Ö., et al.

EACR-AACR-SIC SPECIAL CONFERENCE 2017The Challenges of Optimising Immuno and Targeted TherapiesFrom Cancer Biology to the Clinic, 24 - 27 June 2017, (Summary Text) Sustainable Development

The down regulation of PTENP1 is associated with poor response to FOLFOX in colorectal cancer patients

TUNCA B., AK S., KANAT Ö., DELİGÖNÜL A., ÖZTÜRK E., YILMAZLAR A. T., et al.

EACR-AACR-SIC SPECIAL CONFERENCE 2017The Challenges of Optimising Immuno and Targeted TherapiesFrom Cancer Biology to the Clinic, 24 - 27 June 2017 Sustainable Development

The Cytotoxic and Apoptotic Effects of The Young Shoots Extract of Tamus Communis on Hepatocellular Carcinoma

EGELİ Ü., YURDACAN B., HURİYET H., GÜNEY G., ERYILMAZ I. E., MALYER H., et al.

I.INTERNATIONAL CONGRESS ON MEDICINAL AND AROMATIC PLANTS ”NATURAL AND HEALTHY LiFE, 10 - 12 May 2017, (Full Text)

Cytotoxicity of Juniperus excelsa Aqueous Berry Extract on Castration-Resistant Prostate CancerCells

ERYILMAZ I. E., EGELİ Ü., MALYER H., ÇEÇENER G., ŞAHİN S., TUNCA B.

VI. International Congress of Molecular Medicine, 22 - 25 May 2017 Sustainable Development

Potential role of solid lipid nanoparticles in overcoming the acquired tamoxifen resistance of breast cancers

ÇEÇENER G., GÜNEY ESKİLER G., EGELİ Ü., TUNCA B.

European Biotechnology Congress 2017, 25 - 27 May 2017, (Summary Text) Sustainable Development

In Vitro Cytotoxic and Antitumoral Effects of Juniperus communis Leaf and Berry Extracts on Castration-Resistant Prostate Cancer Cells

ERYILMAZ I. E., EGELİ Ü., ÇEÇENER G., TUNCA B., ŞAHİN S., MALYER H.

15th International Congress of Histochemistry and Cytochemistry “From Molecules to Diseases”, 18 - 21 May 2017 Sustainable Development

Aile öyküsü bulunan polipozis koli tanılı vakalarda APC gen mutasyonlarının önemi

TUNCA B., AKSOY S., ÖZTÜRK E., YILMAZLAR A. T., ZORLUOĞLU A., IŞIK Ö., et al.

16. Türk Kolon ve Rektum Cerrahisi KOngresi, Antalya, Turkey, 16 - 20 May 2017, (Summary Text)

GBM Hastalarında MGMT Gen Metilasyonunun Değerlendirilmesi.

ÇEÇENER G., TUNCA B., EGELİ Ü., TEZCAN G., BEKAR A., TOLUNAY Ş.

III. Multidisipliner Kanser Araştırma Sempozyumu, (Uluslararası katılımlı), Bursa, Turkey, 14 - 17 March 2010, (Summary Text)

Solid Lipid Nanoparticles in Reversing The Acquired Tamoxifen -Resistance